Related Experiment Video
Updated: Jul 16, 2025
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
The Year in Coagulation and Transfusion: Selected Highlights from 2022
Nicole Guinn1, Kenichi Tanaka2, Gabor Erdoes3
1Chief of Neuroanesthesiology, Otolaryngology and Offsite Anesthesia Division, Department of Anesthesiology, Duke University Medical Center, Durham, NC.
Journal of Cardiothoracic and Vascular Anesthesia
|September 10, 2023
Summary
This review summarizes 2022's key advances in transfusion and coagulation for cardiovascular surgery patients, covering anemia, factor Xa inhibitors, testing, concentrates, platelet therapy, and heparin-induced thrombocytopenia.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Coagulation Science
Background:
- Cardiovascular surgery necessitates careful management of blood transfusion and coagulation.
- Annual reviews are crucial for staying abreast of evolving clinical practices and research.
Purpose of the Study:
- To provide a focused summary of significant transfusion and coagulation topics from 2022 relevant to cardiovascular surgery.
- To highlight advancements in patient management and therapeutic strategies.
Main Methods:
- Literature review of key publications from 2022.
- Synthesis of information on anemia, red blood cell transfusion, factor Xa inhibitors, coagulation testing, factor concentrates, platelet therapy, anticoagulation for mechanical circulatory support, and heparin-induced thrombocytopenia.
Main Results:
- Key updates in managing anemia and red blood cell transfusions.
- Advances in the use of factor Xa inhibitors and factor concentrates.
- New insights into coagulation testing, platelet therapy, and anticoagulation for extracorporeal membrane oxygenation.
- Progress in diagnosing and managing heparin-induced thrombocytopenia.
Conclusions:
- Staying updated on transfusion and coagulation advancements is vital for optimizing patient outcomes in cardiovascular surgery.
- The reviewed topics represent critical areas of progress impacting clinical decision-making.
Related Concept Videos
01:09Coagulation
7.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.0K
02:45Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
01:05Introduction to Hemostasis
8.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.2K
01:15Blood Transfusion
603
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
603
01:24Disorders of Hemostasis
987
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
987
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K